Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: The Memphis experience (Q73516877)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226312%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226312%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: The Memphis experience (English)

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(97)00092-8

7 November 2024

1 reference

1 reference

advanced head and neck cancer

1 reference

1 reference

head and neck carcinoma

1 reference

K. T. Robbins

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9226312

7 November 2024

P. Kumar

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9226312

7 November 2024

W. F. Regine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9226312

7 November 2024

F. S. Wong

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9226312

7 November 2024

A. B. Weir

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9226312

7 November 2024

P. Flick

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9226312

7 November 2024

L. E. Kun

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9226312

7 November 2024

R. Palmer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9226312

7 November 2024

T. Murry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9226312

7 November 2024

J. Fontanesi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9226312

7 November 2024

R. Ferguson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9226312

7 November 2024

R. Thomas

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9226312

7 November 2024

W. Hartsell

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9226312

7 November 2024

C. U. Paig

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9226312

7 November 2024

G. Salazar

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9226312

7 November 2024

L. Norfleet

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9226312

7 November 2024

C. B. Hanchett

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9226312

7 November 2024

V. Harrington

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9226312

7 November 2024

H. B. Niell

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9226312

7 November 2024

language of work or name

English

0 references

publication date

1 May 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226312%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

4 November 2019

https://api.elsevier.com/content/article/PII:S0360301697000928?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(97)00092-8

https://api.elsevier.com/content/article/PII:S0360301697000928?httpAccept=text/plain

7 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(97)00092-8

International Journal of Radiation Oncology Biology Physics

7 November 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226312%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226312%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226312%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

263-271

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226312%20AND%20SRC:MED&resulttype=core&format=json

Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck. An RTOG Study

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900092-8

7 January 2021

Characterization of cisplatin-resistant COLO 316 human ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900092-8

7 January 2021

Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck: preliminary report of a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900092-8

7 January 2021

A pilot study of intraarterial chemotherapy with cisplatin in locally advanced head and neck cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900092-8

7 January 2021

Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900092-8

7 January 2021

A critical evaluation of the principles governing the advantages of intra-arterial infusions

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900092-8

7 January 2021

Intra-arterial cisplatin and FUDR in advanced malignancies confined to the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900092-8

7 January 2021

Induction intra-arterial cisplatin and bleomycin in head and neck cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900092-8

7 January 2021

Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Final report of the Head and Neck Contracts Program

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900092-8

7 January 2021

Intraperitoneal cisplatin with systemic thiosulfate protection

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900092-8

7 January 2021

In vitro evaluation of anticancer drugs in relation to development of drug resistance in the human tumor clonogenic assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900092-8

7 January 2021

Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report of intergroup study 0034

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900092-8

7 January 2021

Superselective intra-arterial chemotherapy of advanced paranasal sinus tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900092-8

7 January 2021

Radiation therapy alone or in combination with surgery in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900092-8

7 January 2021

Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Long-term results of the Radiation Therapy Oncology Group study 81-17

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900092-8

7 January 2021

Alternating cisplatin-5-fluorouracil and radiotherapy in head and neck cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900092-8

7 January 2021

Feasibility and efficacy of weekly intraarterial cisplatin in locally advanced (stage III and IV) head and neck cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900092-8

7 January 2021

Treatment of advanced head and neck cancer with concomitant radiation and chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900092-8

7 January 2021

Rapid superselective high-dose cisplatin infusion for advanced head and neck malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900092-8

7 January 2021

Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900092-8

7 January 2021

A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900092-8

7 January 2021

Preoperative reductive chemotherapy for locally advanced carcinoma of the oral cavity, oropharynx, and hypopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900092-8

7 January 2021

Combined simultaneous cisplatin/fluorouracil chemotherapy and split course radiation in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900092-8

7 January 2021

Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900092-8

7 January 2021

Cisplatin, fluorouracil with leucovorin calcium enhancement, and synchronous accelerated radiotherapy in the management of locally advanced head and neck cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900092-8

7 January 2021

Cancer statistics, 1995.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900092-8

7 January 2021

Selective delivery of chemotherapeutic agents with a new catheter system

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900092-8

7 January 2021

Tumor blood flow and systemic shunting in patients receiving intraarterial chemotherapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(97)00092-8

7 November 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226312%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226312%20AND%20SRC:MED&resulttype=core&format=json